[Study on Reentry Strategy and Results of Blood Donors with Single Reagent Reactivity in Wuhan Area].

Q4 Medicine
Ting-Ting Xu, Qin Yu, Song-Qing Ke, Yan Cai, Song-Li Xie, Jing Xiong, Lei Zhao
{"title":"[Study on Reentry Strategy and Results of Blood Donors with Single Reagent Reactivity in Wuhan Area].","authors":"Ting-Ting Xu, Qin Yu, Song-Qing Ke, Yan Cai, Song-Li Xie, Jing Xiong, Lei Zhao","doi":"10.19746/j.cnki.issn.1009-2137.2025.02.033","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To study the results, re-donation situation and characteristics of single-reagent reactive blood donors who were put into the reentry strategy in Wuhan area, explore the rationality and effectiveness of the current reentry strategy, and provide data support for the improvement of the reentry process of blood donors.</p><p><strong>Methods: </strong>From January 2020 to December 2023, blood donors who conform the reentry criteria and voluntarily applied for returning to Wuhan Blood Center were tested and the results were analyzed. According to the reentry strategy, serological testing and nucleic acid testing were carried out in parallel, serological testing was performed by ELISA with reagents from two different manufacturers, and the primary reactive samples were tested by double-well retest, and HBV/HCV/HIV nucleic acid detection was performed by RT-PCR with an individual donor test mode. Supplementary HBcAb testing was applied for HBV single reagent reactivity by chemiluminescence method. Supplementary TP-WB testing was applied for returning blood donors with repeated TP single reagent reactivity. If returning blood donors with HIV single reagent reactivity were repeated single reagent reactivity, the samples were sent to local CDC for confirmatory test.</p><p><strong>Results: </strong>7 098 blood donors were qualified for reentry, 716 donors voluntarily applied for reentry, 436 donors successfully reentry, 251 donors entered the next round, 29 donors could not reentry. The reentry rates for the past four years were 66.67%(42/63), 54.73%(81/148), 60.71%(136/224) and 62.99%(177/281), respectively. Up to December 31, 2023, 275 donors donated blood again, and the donation rates for past four years were 76.19%(32/42), 72.84%(59/81), 61.76%(84/136) and 56.50%(100/177), respectively. After donating blood, 31 donors were disqualified again by blood screening and subjected to permanent deferral. The results of returning to the team had statistical differences in reentry items, educational level, age, and marriage(<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>The current reentry strategy adopted by the blood donation and supply institution can effectively retain part of blood donors, reduce the negative emotions of blood donors and increase blood resources.</p>","PeriodicalId":35777,"journal":{"name":"中国实验血液学杂志","volume":"33 2","pages":"530-537"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国实验血液学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2025.02.033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To study the results, re-donation situation and characteristics of single-reagent reactive blood donors who were put into the reentry strategy in Wuhan area, explore the rationality and effectiveness of the current reentry strategy, and provide data support for the improvement of the reentry process of blood donors.

Methods: From January 2020 to December 2023, blood donors who conform the reentry criteria and voluntarily applied for returning to Wuhan Blood Center were tested and the results were analyzed. According to the reentry strategy, serological testing and nucleic acid testing were carried out in parallel, serological testing was performed by ELISA with reagents from two different manufacturers, and the primary reactive samples were tested by double-well retest, and HBV/HCV/HIV nucleic acid detection was performed by RT-PCR with an individual donor test mode. Supplementary HBcAb testing was applied for HBV single reagent reactivity by chemiluminescence method. Supplementary TP-WB testing was applied for returning blood donors with repeated TP single reagent reactivity. If returning blood donors with HIV single reagent reactivity were repeated single reagent reactivity, the samples were sent to local CDC for confirmatory test.

Results: 7 098 blood donors were qualified for reentry, 716 donors voluntarily applied for reentry, 436 donors successfully reentry, 251 donors entered the next round, 29 donors could not reentry. The reentry rates for the past four years were 66.67%(42/63), 54.73%(81/148), 60.71%(136/224) and 62.99%(177/281), respectively. Up to December 31, 2023, 275 donors donated blood again, and the donation rates for past four years were 76.19%(32/42), 72.84%(59/81), 61.76%(84/136) and 56.50%(100/177), respectively. After donating blood, 31 donors were disqualified again by blood screening and subjected to permanent deferral. The results of returning to the team had statistical differences in reentry items, educational level, age, and marriage(P < 0.05).

Conclusion: The current reentry strategy adopted by the blood donation and supply institution can effectively retain part of blood donors, reduce the negative emotions of blood donors and increase blood resources.

武汉地区单试剂反应性献血者再入策略及结果研究
目的:研究武汉地区纳入再入境策略的单试剂反应性献血者的结果、再献血情况及特点,探讨当前再入境策略的合理性和有效性,为完善献血者再入境流程提供数据支持。方法:对2020年1月至2023年12月符合再入境标准并自愿申请返回武汉市血液中心的献血者进行检测并分析结果。按照再入策略,血清学检测与核酸检测并行进行,血清学检测采用两家不同厂家的试剂,血清学检测采用ELISA法,主要反应样品采用双孔复测,HBV/HCV/HIV核酸检测采用个体供者检测模式RT-PCR。采用化学发光法辅助HBcAb检测HBV单试剂反应性。对回血者进行TP- wb辅助检测,重复TP单试剂反应性。如果携带HIV单试剂反应的回访献血者重复单试剂反应,则将样品送当地疾控中心进行确认性检测。结果:符合再入条件的献血者7 098人,自愿申请再入的716人,成功再入的436人,进入下一轮的251人,不能再入的29人。近4年再入学率分别为66.67%(42/63)、54.73%(81/148)、60.71%(136/224)和62.99%(177/281)。截至2023年12月31日,再次献血者275人,近4年献血率分别为76.19%(32/42)、72.84%(59/81)、61.76%(84/136)和56.50%(100/177)。献血后,31名献血者再次被血液筛查取消资格,并被永久推迟献血。返队结果在再入项目、文化程度、年龄、婚姻等方面有统计学差异(P < 0.05)。结论:目前献血供应机构采取的再入策略可以有效留住部分献血者,减少献血者的负面情绪,增加血液资源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中国实验血液学杂志
中国实验血液学杂志 Medicine-Medicine (all)
CiteScore
0.40
自引率
0.00%
发文量
7331
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信